PLSE
Pulse Biosciences Inc
52.70$
-1.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -20.0% | +83.7% | +89.3% | +41.8% | -40.7% | -1.5% | +31.4% | +43.6% | -24.0% | +123.9% | -27.4% | |
| – | -43.2% | +316.9% | +130.9% | +56.9% | -56.3% | -15.4% | +64.0% | +69.7% | -27.1% | +163.5% | -30.2% | |
| – | -48.6% | -42.1% | +62.1% | +1,409.2% | -86.5% | +80.6% | +129.6% | +113.7% | -27.4% | +166.1% | -31.6% | |
| – | -48.6% | +354.7% | +132.2% | +56.5% | -57.4% | -19.4% | +39.8% | +113.7% | -27.4% | +166.1% | -31.6% | |
| – | – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | +73.1% | -3.6% | +710.7% | -15.4% | +253.4% | -67.7% | +353.9% | – | – | – | – | |
| – | +0.0% | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -8.5% | -9.2% | -10.2% | -11.3% | -12.8% | -14.6% | -17.2% | -20.7% | -26.1% | -35.3% | -52.9% | |
| – | -63.8% | +54.0% | +276.6% | +12.5% | +159.6% | +64.6% | +0.9% | +331.7% | -81.5% | +19.0% | -12.2% | |
| – | +300.3% | +54.0% | +117.8% | +40.4% | +43.5% | +70.1% | +12.3% | -29.8% | +12.2% | +49.9% | -21.2% | |
| – | – | – | – | – | – | – | +123.2% | +49.8% | -41.6% | +28.1% | +15.9% | |
| – | +687.2% | +1.1% | +195.1% | +62.7% | +54.3% | -12.5% | +69.1% | -45.8% | +16.7% | -8.9% | +66.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -15.0% | +85.1% | +81.8% | +44.2% | -53.7% | -25.5% | +55.9% | -106.3% | – | +158.9% | -29.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +201.3% | +45.5% | +34.0% | +15.8% | +21.5% | +12.1% | +20.3% | +21.4% | +41.6% | +21.6% | +15.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.